MIRA INFORM REPORT
|
Report No. : |
319685 |
|
Report Date : |
30.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
CRYSTAL PHARMA, SA |
|
|
|
|
Registered Office : |
Parque Tecnologico, Parcela 113 - Boecillo - 47151 - Valladolid |
|
|
|
|
Country : |
Spain |
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
01.02.1996 |
|
|
|
|
Legal Form : |
Public Limited Company |
|
|
|
|
Line of Business : |
Manufacture
of basic pharmaceutical products |
|
|
|
|
No. of Employees : |
191 (2013) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Spain |
A2 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SPAIN - ECONOMIC OVERVIEW
Spain experienced a prolonged recession in the wake of the global financial crisis. GDP contracted by 3.7% in 2009, ending a 16-year growth trend, and continued contracting through most of 2013. Economic growth resumed briefly in late 2013, albeit only modestly, as credit contraction in the private sector, fiscal austerity, and high unemployment continued to weigh on domestic consumption and investment. Exports, however, have been resilient throughout the economic downturn and helped to bring Spain's current account into surplus in 2013 for the first time since 1986. The unemployment rate rose from a low of about 8% in 2007 to more than 26% in 2013, straining Spain's public finances as spending on social benefits increased while tax revenues fell. Spain’s budget deficit peaked at 11.4% of GDP in 2010. Spain gradually reduced the deficit to just under 7% of GDP in 2013-14, slightly above the 6.5% target negotiated between Spain and the EU. Public debt has increased substantially – from 60.1% of GDP in 2010 to more than 97% in 2014. Rising labor productivity, moderating labor costs, and lower inflation have helped to improve foreign investor interest in the economy and to reduce government borrowing costs. The government's ongoing efforts to implement reforms - labor, pension, health, tax, and education - are aimed at supporting investor sentiment. The government also has shored up struggling banks exposed to Spain's depressed domestic construction and real estate sectors by successfully completing an EU-funded restructuring and recapitalization program in January 2014. Recently increased private consumption helped bring real GDP growth back into positive territory at 1.3% in 2014, and labor reforms prompted a modest reduction in the unemployment rate, from more than 26% in 2013 to 24% in 2014. Despite the uptic in economic activity, inflation dropped sharply, from 1.5% in 2013 to flat in 2014. Spain’s 2015 budget, published in September 2014, rolls back some recently imposed taxes in advance of national elections in November 2015 and leaves untouched the country’s value-added tax (VAT) regime, which generates significantly lower revenue than the EU average. Spain’s borrowing costs are dramatically lower since their peak in mid-2012.
|
Source
: CIA |
EXECUTIVE
SUMMARY
|
Name: |
CRYSTAL
PHARMA, SA |
|
NIF
/ Fiscal code: |
A40147753 |
|
Status: |
ACTIVE |
|
Incorporation
Date: |
01/02/1996 |
|
Register Data |
Register
Section 8 Sheet 7941 |
|
Last Publication in BORME: |
14/01/2014
[Appointments] |
|
Last
Published Account Deposit: |
2013 |
|
Share
Capital: |
2.000.000 |
|
Localization: |
PARQUE
TECNOLOGICO, PARCELA 113 - BOECILLO - 47151 - VALLADOLID |
|
Telephone
- Fax - Email - Website: |
Telephone.
983 548 072 Email. cristalpharma@cristalpharma.com Website.
www.cristalpharma.com |
|
Number
of Branches |
1 |
|
Activity: |
|
|
NACE: |
2110
- Manufacture of basic pharmaceutical products |
|
Registered
Trademarks: |
|
|
Audited
/ Opinion: |
Si
/ |
|
Tenders
and Awards: |
0
for a total cost of 0 |
|
Subsidies: |
36
for a total cost of 6133006 |
|
Quality
Certificate: |
No |
Defaults, Legal Claims and Insolvency
Proceedings :
|
|
Number |
Amount (€) |
Most Recent Entry |
|
Insolvency Proceedings, Bankruptcy and
Suspension of Payments |
Unpublished |
--- |
--- |
|
Defaults on debt with Financial Institutions
and Large Companies |
None |
--- |
--- |
|
Judicial Claims (Notices, Executive
Proceedings, Attachments, Auctions, Bad Debt) |
None |
0 |
--- |
|
Proceedings heard by the Civil Court |
Unpublished |
0 |
--- |
|
Proceedings heard by the Labour Court |
Unpublished |
0 |
--- |
|
Partners: |
|
|
|
GADEA
GRUPO FARMACEUTICO SL |
100
% |
|
|
Shares: |
1 |
|
|
Other
Links: |
5 |
|
|
No.
of Active Corporate Bodies: |
SINGLE
ADMINISTRATOR 1 |
|
|
Ratios |
2013 |
2012 |
Change |
|
|
Nº
of employees: |
191 |
|
|
|
|
|
|
|
Guarantees: |
|
|
Properties
Registered: |
Company
NO, Administrator NO |
|
Financing
/ Guarantee Sources : |
Sources
YES, Guarantees YES |
INVESTIGATION
SUMMARY
The company was incorporated in 1996, engaged in the manufacture of
pharmaceuticals. Its commercial scope is national and international. It belongs
to the group of companies headed by "GADEA GRUPO FARMACÉUTICO". The
consulted sources do not have any bad comment about it. According to all this
information, commercial relations can be envisaged in normal credit operations.
Identification
|
Social Denomination: |
CRYSTAL
PHARMA, SA |
|
NIF / Fiscal code: |
A40147753 |
|
Corporate Status: |
ACTIVE |
|
Start of activity: |
1996 |
|
Registered Office: |
PARQUE
TECNOLOGICO, PARCELA 113 |
|
Locality: |
BOECILLO |
|
Province: |
VALLADOLID |
|
Postal Code: |
47151 |
|
Telephone: |
983 548 072 |
|
Fax: |
983 548 113 |
|
Website: |
www.cristalpharma.com |
|
Email: |
cristalpharma@cristalpharma.com |
|
Interviewed Person: |
Information
obtained through indirect sources, as people responsible for the company
refused to provide information. |
Branch
Offices
|
Address |
Postal Code |
City |
Province |
|
parque Tecnológico Parc- 105 |
47151 |
Boecillo |
Valladolid |
Activity
|
NACE: |
2110 |
|
Legal Form: |
MANUFACTURE, MARKETING, PLANNING, STUDY, PROGRAMMING, ACQUISITION, HANDLING AND INTERIOR EXTERIOR TRAFFIC OF RAW MATERIALS, INTERMEDIATE GOODS, SEMI AND PROCESSED PRODUCTS INTENDED FOR THE CHEMICAL, PHARMACEUTICAL, COSMETIC, VETERINARY AND FOOD INDUSTRY |
|
Additional Information: |
Manufacture of pharmaceuticals. |
|
Additional Address: |
PARQUE TECNOLOGICO, PARCELA 113, 47151 BOECILLO, VALLADOLID, reception area and offices. The fiscal domicile is at No. 105 of the same address. |
|
Franchise: |
No |
|
Import / export: |
IMPORTS / EXPORTS |
|
Future Perspective: |
Consolidation |
|
Industry situation: |
Maturity |
Number
of Employees
|
Year |
No. of employees |
Established |
Incidentals |
|
2013 |
191 |
|
|
Chronological
Summary
|
Year |
Act |
|
1996 |
Appointments/ Re-elections (1) Change of Social address (1)
Company Formation (1) Increase of Capital (1) Statutory Modifications (1) |
|
1997 |
Accounts deposit (year 1996) |
|
1998 |
Accounts deposit (year 1997) |
|
1999 |
Accounts deposit (year 1998) |
|
2000 |
Accounts deposit (year 1999) Increase of Capital (2) |
|
2001 |
Accounts deposit (year 2000) Appointments/ Re-elections
(2) |
|
2002 |
Accounts deposit (year 2001) |
|
2003 |
Accounts deposit (year 2002) Increase of Capital (1) |
|
2004 |
Accounts deposit (year 2003) Increase of Capital (2) |
|
2005 |
Accounts deposit (year 2004) Appointments/ Re-elections
(1) Cessations/ Resignations/ Reversals (1) |
|
2006 |
Accounts deposit (year 2005) |
|
2007 |
Accounts deposit (year 2006) Appointments/ Re-elections
(1) Cessations/ Resignations/ Reversals (1) Declaration of Sole Propietorship
(1) Statutory Modifications (1) |
|
2008 |
Accounts deposit (year 2007) Appointments/ Re-elections
(2) |
|
2009 |
Accounts deposit (year 2008) |
|
2010 |
Accounts deposit (year 2009) Cessations/ Resignations/
Reversals (1) |
|
2011 |
Accounts deposit (year 2010) Appointments/ Re-elections
(1) Take-over Merger (2) |
|
2012 |
Accounts deposit (year 2011) Change of Social Purpose (1)
Statutory Modifications (1) Take-over Merger (1) |
|
2013 |
Accounts deposit (year 2012) Appointments/ Re-elections
(2) |
|
2014 |
Accounts deposit (year 2013) Appointments/ Re-elections
(1) |
Breakdown
of Owners' Equity
|
Registered Capital: |
2.000.000 |
|
Paid up capital: |
2.000.000 |
Updated
Evolution of the Subscribed and Paid-in Capital
|
Publishing Date |
Registration Type |
Capital Subscribed |
Paid up capital |
Underwritten
result |
Disbursed Result |
|
10/04/1996 |
Company Formation |
60.101 |
60.101 |
60.101 |
60.101 |
|
12/12/1996 |
Increase of
Capital |
540.911 |
540.911 |
601.012 |
601.012 |
|
28/09/2000 |
Increase of
Capital |
210.354 |
210.354 |
811.366 |
811.366 |
|
30/12/2000 |
Increase of
Capital |
23.439 |
23.439 |
834.806 |
834.806 |
|
12/02/2003 |
Increase of
Capital |
465.200 |
465.200 |
1.300.000 |
1.300.000 |
|
10/02/2004 |
Increase of
Capital |
300.000 |
300.000 |
1.600.000 |
1.600.000 |
|
10/02/2004 |
Increase of
Capital |
400.000 |
400.000 |
2.000.000 |
2.000.000 |
Active
Social Bodies
|
Post published |
Social Body's Name |
Appointment Date |
Other Positions in this Company |
|
SINGLE PARTNER |
GADEA PHARMACEUTICAL GROUP SL |
25/05/2007 |
2 |
|
SINGLE ADMINISTRATOR |
GADEA GRUPO FARMACEUTICO SL |
07/05/2013 |
2 |
|
PROXY |
GALLO NIETO FRANCISCO JAVIER |
07/07/2008 |
1 |
|
ACCOUNTS' AUDITOR / HOLDER |
DELOITTE SL |
07/01/2014 |
1 |
Historical
Social Bodies
|
Social Body's Name |
Post published |
End Date |
Other Positions in this Company |
|
3-GUTINVER SL |
MEMBER OF THE BOARD |
25/05/2007 |
2 |
|
|
CHIEF EXECUTIVE OFFICER |
25/05/2007 |
|
|
ERNST & YOUNG SL |
ACCOUNTS' AUDITOR / HOLDER |
30/03/2011 |
3 |
|
|
ACCOUNTS' AUDITOR / HOLDER |
28/01/2013 |
|
|
|
ACCOUNTS' AUDITOR / HOLDER |
07/01/2014 |
|
|
GADEA GRUPO FARMACEUTICO SL |
SINGLE ADMINISTRATOR |
07/05/2013 |
2 |
|
GADEA PHARMACEUTICAL GROUP SL |
SINGLE ADMINISTRATOR |
07/05/2013 |
2 |
|
GALVEZ HERNANDEZ LUIS |
MEMBER OF THE BOARD |
27/02/2001 |
6 |
|
|
MEMBER OF THE BOARD |
25/01/2005 |
|
|
|
MEMBER OF THE BOARD |
25/05/2007 |
|
|
|
SECRETARY |
27/02/2001 |
|
|
|
SECRETARY |
25/01/2005 |
|
|
|
SECRETARY |
25/05/2007 |
|
|
GBB PHARMINVEST 99 SL |
MEMBER OF THE BOARD |
25/05/2007 |
2 |
|
|
PRESIDENT |
25/05/2007 |
|
|
GUTIERREZ FUENTES LUIS GERARDO |
MEMBER OF THE BOARD |
27/02/2001 |
4 |
|
|
CHIEF EXECUTIVE OFFICER |
27/02/2001 |
|
|
|
CHIEF EXECUTIVE OFFICER |
25/01/2005 |
|
|
|
MEMBER OF THE BOARD |
25/01/2005 |
|
|
MARTIN JUAREZ JORGE |
PRESIDENT |
27/02/2001 |
5 |
|
|
MEMBER OF THE BOARD |
27/02/2001 |
|
|
|
MEMBER OF THE BOARD |
25/01/2005 |
|
|
|
PRESIDENT |
25/01/2005 |
|
|
|
PROXY |
02/06/2010 |
|
|
MELENDO BAÑOS JAIME |
MEMBER OF THE BOARD |
27/02/2001 |
3 |
|
|
MEMBER OF THE BOARD |
25/01/2005 |
|
|
|
MEMBER OF THE BOARD |
25/05/2007 |
|
Socia
Defaults, Legal Claims and Insolvency Proceedings
Section enabling assessment of the degree of compliance of the
company queried with its payment obligations. It provides information on the
existence and nature of all stages of Insolvency and Legal Proceedings
published with reference to the Company in the country's various Official
Bulletins and national newspapers, as well Defaults Registered in the main
national credit bureaus (ASNEF Industrial and RAI ).
> Summary
Chronological summary
|
|
|
Number
of Publications |
Amount
(_) |
Start
date |
End
date |
|
Insolvency
Proceedings, Bankruptcy and Suspension of Payments |
|
Unpublished |
--- |
--- |
--- |
|
Request/Declaration |
|
0 |
--- |
date |
|
|
Proceedings |
|
--- |
--- |
|
--- |
|
Resolution |
|
--- |
--- |
|
--- |
|
Defaults
on debt with Financial Institutions and Large Companies |
Bank
and Commercial Delinquency |
None |
0 |
|
|
|
Status:
Friendly |
|
--- |
|
|
|
|
Status:
Pre-Litigation |
|
--- |
|
|
|
|
Status:
Litigation |
|
--- |
|
|
|
|
Status:
Non-performing |
|
--- |
|
|
|
|
Status:
insolvency proceedings, bankruptcy and suspension of payments |
|
--- |
|
|
|
|
Other
status |
|
--- |
|
|
|
|
Legal
and Administrative Proceedings |
|
Unpublished |
--- |
|
|
|
Notices
of defaults and enforcement |
|
--- |
--- |
|
--- |
|
Seizures |
|
--- |
--- |
|
--- |
|
Auctions |
|
--- |
--- |
|
--- |
|
Declarations
of insolvency and bad debt |
|
--- |
--- |
|
--- |
|
Proceedings
heard by the Civil Court |
|
Unpublished |
--- |
|
|
|
Proceedings
heard by the Labour Court |
|
Unpublished |
--- |
|
|
> Basis for
scoring
|
Positive Factors |
Adverse Factors |
|
No judicial claims have been detected in the Official Gazettes, regarding any Entity's outstanding debts with the Tax Bureau or Social Security administrations, as submitted by Courts of the various court jurisdictions. No irregular payment performance has been detected based on information obtained from credit bureaus. It is one of the major domestic companies in terms of sales volume. Significant level of financial autonomy. The asset is financed mostly with equity and financing with maturity exceeding one year, providing a solid financial structure. CRYSTAL PHARMA, SA 's borrowing cost is appropriate according to its volume of external financing sources. |
|
Probability
of default
> Estimated Probability
of Default for the next 12 months: 0.245 %
|
Sector in which comparison is carried out: 211 Manufacture of basic pharmaceutical products |
|
Relative Position:
|
The company's comparative analysis with the rest of the companies that comprise the sector, shows the company holds a better position with regard to the probability of non-compliance.
The 96.00% of the companies of the sector CRYSTAL PHARMA, SA belongs to show a higher probability of non-compliance.
The probability of the company's non-compliance with its payment obligations within deadlines estimated by our qualifications models is 0.245%.
In the event they fail to comply with the payment, the seriousness of the loss will depend on factors such as the promptness of the commencement of the charging management, the existence of executive documents which match the credit or the existence of guarantees and free debt assets under the name of the debtor. Therefore, the probability of non-compliance should not be solely interpreted as the total loss of the owed amount.
LEGAL
CLAIMS
Summary of Judicial Claims
|
|
|
|
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
Link List
|
ABSORBS TO: |
1 Entities |
|
HAS IN ITS ADMINISTRATION BOARD TO: |
1 Entities |
|
IS RELATED WITH: |
3 Entities |
|
PARTICIPATES IN: |
1 Entities |
|
SHAREHOLDERS: |
1 Entities |
> Shareholders
|
Relationship |
Entity |
Province |
Shareholding stake |
|
SHAREHOLDERS |
GADEA GRUPO FARMACEUTICO SL |
VALLADOLID |
100 |
|
PARTICIPATES IN |
SOLEA PHARMA, S.A. |
|
100 |
> Other relationships
|
Relationship |
Entity |
Province |
Shareholding stake |
|
IS RELATED WITH |
| | |
|
|
|
|
GADEA BIOPHARMA SL |
LEON |
|
|
IS RELATED WITH |
GENTEC SA |
BARCELONA |
|
|
|
GADEA BIOPHARMA SL |
LEON |
|
|
ABSORBS TO |
RAGACTIVES SL |
VALLADOLID |
|
|
HAS IN ITS ADMINISTRATION BOARD TO |
GADEA GRUPO FARMACEUTICO SL |
VALLADOLID |
|
Turnover
|
Total Sales 2013 |
59.275.000 |
E
Estimated
Balance
|
ESTIMATED FINANCIAL INFORMATION 2.014 -NON-CURRENT
ASSETS...................................................21.086.000 Euro/s
-CURRENT
ASSETS............................................................37.680.000 Euro/s
-NET
EQUITY.......................................................................31.110.000
Euro/s -NON-CURRENT
LIABILITIES..................................................5.617.000 Euro/s
-CURRENT LIABILITIES.........................................................22.039.000
Euro/s -TOTAL ASSETS &
LIABILITIES...........................................58.766.000 Euro/s
-SALES
(2.014)....................................................................59.900.000
Euro/s |
Financial
Accounts and Balance Sheets
Financial Years
Presented
|
Ejercicio |
Tipo de Cuentas Anuales |
Fecha Presentacion |
|
2013 |
Normales |
July 2014 |
|
2012 |
Normales |
September 2013 |
|
2011 |
Normales |
September 2012 |
|
2010 |
Normales |
September 2011 |
|
2009 |
Normales |
September 2010 |
|
2008 |
Normales |
October 2009 |
|
2007 |
Normales |
November 2008 |
|
2006 |
Normales |
December 2007 |
|
2005 |
Normales |
November 2006 |
|
2004 |
Normales |
September 2005 |
|
2003 |
Normales |
September 2004 |
|
2002 |
Normales |
September 2003 |
|
2001 |
Normales |
July 2002 |
|
2000 |
Normales |
July 2001 |
|
1999 |
Normales |
September 2000 |
|
1998 |
Normales |
July 1999 |
|
1997 |
Normales |
July 1998 |
|
1996 |
Normales |
July 1997 |
The data in the
report regarding the last Company Accounts submitted by the company is taken
from the TRADE REGISTER serving the region in which the company's address is
located 31/12/2013
> Normal format Balance in accordance with the New Accounting Plan 2007
Information
corresponding to the fiscal year
2013 2012 2011 2010 2009 is taken from information
submitted to the TRADE REGISTER. Data corresponding to fiscal years before
2013 2012 2011 2010 2009 has been compiled based on
the equivalence criteria stipulated in Act JUS/206/2009. Where the provisions
of the Act did not establish relevant equivalence criteria. To view details on
the methodology.
|
|
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
|
Assets |
2013 |
2012 |
2011 |
2010 |
2009 |
|
A) NON-CURRENT ASSETS:
11000 |
20.866.000,00 |
14.004.000,00 |
13.323.000,00 |
9.265.480,00 |
11.008.838,00 |
|
I.
Intangible fixed assets : 11100 |
1.475.000,00 |
1.907.000,00 |
3.150.000,00 |
987.256,00 |
1.537.343,00 |
|
1. Development: 11110 |
140.000,00 |
310.000,00 |
630.000,00 |
987.256,00 |
1.536.825,00 |
|
2. Concessions: 11120 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Patents, licencing, trade marks and similar: 11130 |
526.000,00 |
896.000,00 |
1.820.000,00 |
0,00 |
0,00 |
|
4. Goodwill: 11140 |
699.000,00 |
699.000,00 |
699.000,00 |
0,00 |
0,00 |
|
5. IT applications: 11150 |
110.000,00 |
2.000,00 |
1.000,00 |
0,00 |
517,00 |
|
6. Investigation: 11160 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Intellectual property: 11180 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
8. Greenhouse gas emission allowance: 11190 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
9. Other intangible fixed assets. : 11170 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Tangible fixed assets : 11200 |
7.861.000,00 |
8.372.000,00 |
9.983.000,00 |
8.098.781,00 |
8.268.989,00 |
|
1. Land and buildings: 11210 |
3.790.000,00 |
3.907.000,00 |
3.986.000,00 |
3.072.614,00 |
2.805.346,00 |
|
2. Technical installations and other tangible fixed assets:
11220 |
3.416.000,00 |
4.431.000,00 |
5.872.000,00 |
4.746.870,00 |
5.243.282,00 |
|
3. Tangible asset in progress and advances: 11230 |
655.000,00 |
34.000,00 |
125.000,00 |
279.298,00 |
220.361,00 |
|
III. Real
estate investment: 11300 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Land: 11310 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Buildings: 11320 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Long-term investments in Group companies and associates : 11400 |
11.194.000,00 |
3.610.000,00 |
0,00 |
0,00 |
777.537,00 |
|
1. Equity instruments: 11410 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Credits to businesses: 11420 |
11.194.000,00 |
3.610.000,00 |
0,00 |
0,00 |
777.537,00 |
|
3. Debt securities: 11430 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 11440 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other financial assets : 11450 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Other investments: 11460 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V.
Long-term financial investments: 11500 |
19.000,00 |
19.000,00 |
19.000,00 |
11.360,00 |
10.114,00 |
|
1. Equity instruments: 11510 |
10.000,00 |
10.000,00 |
10.000,00 |
5.730,00 |
5.730,00 |
|
2. Credits to third parties : 11520 |
9.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Debt securities: 11530 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 11540 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other financial assets : 11550 |
0,00 |
9.000,00 |
9.000,00 |
5.630,00 |
4.384,00 |
|
6. Other investments: 11560 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Assets for deferred tax : 11600 |
317.000,00 |
96.000,00 |
171.000,00 |
168.084,00 |
414.856,00 |
|
VII.
Non-current trade debts : 11700 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B) CURRENT ASSETS: 12000 |
37.287.000,00 |
36.464.000,00 |
31.405.000,00 |
22.997.076,00 |
16.215.068,00 |
|
I.
Non-current assets held for sale : 12100 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Stocks: 12200 |
18.195.000,00 |
15.047.000,00 |
15.559.000,00 |
10.350.520,00 |
8.261.684,00 |
|
1. Commercial: 12210 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Primary material and other supplies: 12220 |
4.428.000,00 |
3.471.000,00 |
3.968.000,00 |
2.972.693,00 |
1.972.894,00 |
|
3. Work in progress: 12230 |
5.945.000,00 |
5.622.000,00 |
3.480.000,00 |
2.183.866,00 |
2.859.094,00 |
|
a) Of long-term production cycle :
12231 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Of short-term production cycle :
12232 |
5.945.000,00 |
5.622.000,00 |
3.480.000,00 |
2.183.866,00 |
2.859.094,00 |
|
4. Finished goods: 12240 |
7.801.000,00 |
5.885.000,00 |
8.110.000,00 |
5.186.500,00 |
3.429.696,00 |
|
a) Of long-term production cycle :
12241 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Of short-term production cycle :
12242 |
7.801.000,00 |
5.885.000,00 |
8.110.000,00 |
5.186.500,00 |
3.429.696,00 |
|
5. By-products, residues and recycled materials: 12250 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Advances to suppliers: 12260 |
21.000,00 |
69.000,00 |
1.000,00 |
7.461,00 |
0,00 |
|
III.
Trade debtors and others receivable accounts: 12300 |
16.069.000,00 |
15.456.000,00 |
13.402.000,00 |
10.136.238,00 |
6.627.834,00 |
|
1. Trade debtors / accounts receivable: 12310 |
12.340.000,00 |
12.439.000,00 |
10.598.000,00 |
9.212.908,00 |
4.504.213,00 |
|
a) Long-term receivables from sales and
services supplied : 12311 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Customers for sales and provisions of
services : 12312 |
12.340.000,00 |
12.439.000,00 |
10.598.000,00 |
9.212.908,00 |
4.504.213,00 |
|
2. Customers, Group companies and associates : 12320 |
2.233.000,00 |
1.647.000,00 |
1.516.000,00 |
411.571,00 |
976.192,00 |
|
3. Other accounts receivable: 12330 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Personnel: 12340 |
5.000,00 |
6.000,00 |
0,00 |
0,00 |
37.648,00 |
|
5. Assets for deferred tax: 12350 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Other debtors, including tax and social security:
12360 |
1.491.000,00 |
1.364.000,00 |
1.288.000,00 |
511.759,00 |
1.109.781,00 |
|
7. Called up share capital: 12370 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Short-term investments in Group companies and associates: 12400 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Equity instruments: 12410 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Credits to businesses: 12420 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Debt securities: 12430 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 12440 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other financial assets : 12450 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Other investments: 12460 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V.
Short-term financial investments : 12500 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Equity instruments: 12510 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Credits to businesses: 12520 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Debt securities: 12530 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 12540 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other financial assets : 12550 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Other investments: 12560 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Short-term accruals: 12600 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VII. Cash
and other equivalent liquid assets : 12700 |
3.023.000,00 |
5.961.000,00 |
2.444.000,00 |
2.510.318,00 |
1.325.550,00 |
|
1. Treasury: 12710 |
3.023.000,00 |
3.161.000,00 |
2.444.000,00 |
2.500.318,00 |
1.325.550,00 |
|
2. Other equivalent liquid assets: 12720 |
0,00 |
2.800.000,00 |
0,00 |
10.000,00 |
0,00 |
|
TOTAL ASSETS (A + B) :
10000 |
58.153.000,00 |
50.468.000,00 |
44.728.000,00 |
32.262.556,00 |
27.223.906,00 |
|
|
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
|
Liabilities and Net
Worth |
2013 |
2012 |
2011 |
2010 |
2009 |
|
A) NET WORTH: 20000 |
30.785.000,00 |
30.005.000,00 |
26.180.000,00 |
13.160.443,00 |
13.195.162,00 |
|
A-1)
Shareholders' equity: 21000 |
30.453.000,00 |
29.458.000,00 |
25.394.000,00 |
12.247.317,00 |
12.099.388,00 |
|
I. Capital:
21100 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
|
1. Registered capital : 21110 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
|
2. (Uncalled capital): 21120 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II. Share
premium: 21200 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Reserves: 21300 |
20.558.000,00 |
20.993.000,00 |
16.266.000,00 |
7.349.388,00 |
7.934.839,00 |
|
1. Legal and statutory: 21310 |
400.000,00 |
400.000,00 |
400.000,00 |
400.000,00 |
400.000,00 |
|
2. Other reserves: 21320 |
20.158.000,00 |
20.593.000,00 |
15.866.000,00 |
6.949.388,00 |
7.534.839,00 |
|
3. Revaluation reserves: 21330 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
(Common stock equity): 21400 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V.
Results from previous periods: 21500 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Brought forward: 21510 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. (Negative results from previous periods): 21520 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI. Other
shareholders' contributions: 21600 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VII.
Result of the period: 21700 |
7.895.000,00 |
6.465.000,00 |
7.128.000,00 |
2.897.929,00 |
2.164.549,00 |
|
VIII.
(Interim dividend): 21800 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IX. Other
net worth instruments: 21900 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A-2)
Adjustments due to changes in value: 22000 |
-15.000,00 |
-45.000,00 |
-50.000,00 |
-42.195,00 |
-35.071,00 |
|
I. Financial
assets held for sale: 22100 |
0,00 |
-45.000,00 |
-50.000,00 |
0,00 |
0,00 |
|
II. Hedge
operations: 22200 |
-15.000,00 |
0,00 |
0,00 |
-42.195,00 |
-35.071,00 |
|
III. Linked
non-current assets and liabilities held for sale : 22300 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Exchange rate difference: 22400 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V. Other:
22500 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A-3)
Received subsidies, donations and legacies: 23000 |
347.000,00 |
592.000,00 |
836.000,00 |
955.321,00 |
1.130.845,00 |
|
B) NON-CURRENT LIABILITIES:
31000 |
5.559.000,00 |
3.437.000,00 |
3.331.000,00 |
9.105.589,00 |
1.455.952,00 |
|
I.
Long-term provisions: 31100 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Long-term employee benefits liability: 31110 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Environmental actions: 31120 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Restructuring provisions: 31130 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Other provisions: 31140 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II
Long-term creditors: 31200 |
4.939.000,00 |
2.611.000,00 |
1.968.000,00 |
3.062.273,00 |
892.018,00 |
|
1. Liabilities and other securities: 31210 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Amounts owed to credit institutions: 31220 |
4.831.000,00 |
2.235.000,00 |
1.324.000,00 |
2.110.430,00 |
769.153,00 |
|
3. Creditors from financial leasing: 31230 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 31240 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other financial liabilities : 31250 |
108.000,00 |
376.000,00 |
644.000,00 |
951.843,00 |
122.865,00 |
|
III.
Long-term debts with Group companies and associates: 31300 |
0,00 |
0,00 |
242.000,00 |
5.574.433,00 |
0,00 |
|
IV. Liabilities
for deferred tax: 31400 |
620.000,00 |
826.000,00 |
1.121.000,00 |
468.883,00 |
563.934,00 |
|
V.
Long-term accruals: 31500 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Non-current trade creditors : 31600 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VII.
Special long-term debts : 31700 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
C) CURRENT LIABILITIES :
32000 |
21.809.000,00 |
17.026.000,00 |
15.217.000,00 |
9.996.524,00 |
12.572.792,00 |
|
I. Liabilities
linked to non-current assets held for sale: 32100 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Short-term provisions: 32200 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Provisions from greenhouse gas emission allowance:
32210 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Other provisions: 32220 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Short-term creditors : 32300 |
8.193.000,00 |
6.360.000,00 |
3.586.000,00 |
1.968.362,00 |
2.997.840,00 |
|
1. Liabilities and other securities: 32310 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Amounts owed to credit institutions: 32320 |
7.737.000,00 |
5.985.000,00 |
3.191.000,00 |
1.584.028,00 |
2.908.525,00 |
|
3. Creditors from financial leasing: 32330 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Derivatives : 32340 |
22.000,00 |
65.000,00 |
71.000,00 |
60.279,00 |
50.101,00 |
|
5. Other financial liabilities : 32350 |
434.000,00 |
310.000,00 |
324.000,00 |
324.054,00 |
39.214,00 |
|
IV.
Short-term debts with Group companies and associates: 32400 |
2.689.000,00 |
2.219.000,00 |
2.517.000,00 |
819.186,00 |
4.575.437,00 |
|
V. Trade creditors
and other accounts payable: 32500 |
10.927.000,00 |
8.447.000,00 |
9.114.000,00 |
7.208.976,00 |
4.999.515,00 |
|
1. Suppliers: 32510 |
7.625.000,00 |
5.619.000,00 |
6.592.000,00 |
4.448.591,00 |
1.875.316,00 |
|
a) Long-term debts : 32511 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Short-term debts : 32512 |
7.625.000,00 |
5.619.000,00 |
6.592.000,00 |
4.448.591,00 |
1.875.316,00 |
|
2. Suppliers, Group companies and associates: 32520 |
679.000,00 |
306.000,00 |
517.000,00 |
739.443,00 |
1.933.174,00 |
|
3. Other creditors: 32530 |
1.122.000,00 |
1.544.000,00 |
1.307.000,00 |
1.406.838,00 |
697.965,00 |
|
4. Personnel (remuneration due): 32540 |
556.000,00 |
517.000,00 |
436.000,00 |
310.352,00 |
276.103,00 |
|
5. Liabilities for current tax: 32550 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Other accounts payable to Public Administrations.:
32560 |
364.000,00 |
309.000,00 |
262.000,00 |
204.629,00 |
166.433,00 |
|
7. Advances from clients: 32570 |
581.000,00 |
152.000,00 |
0,00 |
99.122,00 |
50.525,00 |
|
VI. Short-term
accruals: 32600 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VII.
Special short-term debts : 32700 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
TOTAL NET WORTH AND
LIABILITIES (A + B + C) : 30000 |
58.153.000,00 |
50.468.000,00 |
44.728.000,00 |
32.262.556,00 |
27.223.906,00 |
|
|
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
ORIGINAL |
|
Profit and Loss |
2013 |
2012 |
2011 |
2010 |
2009 |
|
1. Net turnover: 40100 |
59.275.000,00 |
58.580.000,00 |
49.097.000,00 |
33.367.837,00 |
22.716.871,00 |
|
a) Sales:
40110 |
59.040.000,00 |
58.453.000,00 |
49.029.000,00 |
32.900.587,00 |
22.492.865,00 |
|
b)
Rendering of services: 40120 |
235.000,00 |
127.000,00 |
68.000,00 |
467.250,00 |
224.006,00 |
|
c) Income
of financial nature of holding companies: 40130 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Changes in stocks of
finished goods and work in progress: 40200 |
2.240.000,00 |
-84.000,00 |
2.872.000,00 |
1.081.575,00 |
1.284.548,00 |
|
3. Works carried out by the
company for its assets: 40300 |
0,00 |
0,00 |
0,00 |
0,00 |
573.491,00 |
|
4. Supplies : 40400 |
-36.227.000,00 |
-34.761.000,00 |
-26.847.000,00 |
-20.842.429,00 |
-14.029.246,00 |
|
a) Stock
consumption: 40410 |
0,00 |
-2.571.000,00 |
-2.757.000,00 |
-2.221.387,00 |
-1.494.504,00 |
|
b)
Consumption of raw materials and miscellaneous consumable ones: 40420 |
-33.821.000,00 |
-28.834.000,00 |
-20.251.000,00 |
-17.193.455,00 |
-11.635.881,00 |
|
c) Works
carried out by other companies: 40430 |
-2.406.000,00 |
-3.356.000,00 |
-3.839.000,00 |
-1.427.587,00 |
-898.861,00 |
|
d)
Impairment of stock, primary material and other supplies: 40440 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Other operating income:
40500 |
361.000,00 |
81.000,00 |
754.000,00 |
357.948,00 |
673.460,00 |
|
a)
Auxiliary income and other from current management: 40510 |
355.000,00 |
79.000,00 |
152.000,00 |
146.275,00 |
468.404,00 |
|
b)
Operation subsidies included in the Period's result: 40520 |
6.000,00 |
2.000,00 |
602.000,00 |
211.673,00 |
205.057,00 |
|
6. Personnel costs:
40600 |
-6.914.000,00 |
-6.476.000,00 |
-4.918.000,00 |
-3.509.813,00 |
-3.427.413,00 |
|
a) Wages,
salaries et al.: 40610 |
-5.221.000,00 |
-4.901.000,00 |
-3.691.000,00 |
-2.634.583,00 |
-2.531.002,00 |
|
b) Social
security costs: 40620 |
-1.693.000,00 |
-1.575.000,00 |
-1.227.000,00 |
-875.230,00 |
-896.411,00 |
|
c)
Provisions : 40630 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Other operating costs:
40700 |
-6.348.000,00 |
-5.626.000,00 |
-7.080.000,00 |
-4.452.477,00 |
-3.047.446,00 |
|
a)
External services: 40710 |
-6.073.000,00 |
-5.410.000,00 |
-7.028.000,00 |
-4.176.193,00 |
-3.025.546,00 |
|
b) Taxes:
40720 |
-23.000,00 |
-43.000,00 |
-32.000,00 |
-16.199,00 |
-17.270,00 |
|
c) Losses,
impairments and variation in provisions from trade operations : 40730 |
0,00 |
0,00 |
-20.000,00 |
-3.592,00 |
-1.110,00 |
|
d) Other
current management expenditure : 40740 |
-252.000,00 |
-173.000,00 |
0,00 |
-256.493,00 |
-3.520,00 |
|
e)
Expenses due to greenhouse gas emissions: 40750 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
8. Amortisation of fixed
assets: 40800 |
-2.094.000,00 |
-3.108.000,00 |
-4.455.000,00 |
-2.112.272,00 |
-1.929.221,00 |
|
9. Allocation of subsidies of
non-financial fixed assets and other: 40900 |
349.000,00 |
348.000,00 |
353.000,00 |
403.147,00 |
344.587,00 |
|
10. Excess provisions :
41000 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
11. Impairment and result of transfers
of fixed assets: 41100 |
0,00 |
0,00 |
-4.000,00 |
-895,00 |
-25.689,00 |
|
a)
Impairment and losses : 41110 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b)
Results for transfers and other : 41120 |
0,00 |
0,00 |
-4.000,00 |
-895,00 |
-25.689,00 |
|
c)
Impairment and profit due to disposals of assets of holding companies:
41130 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
12. Negative difference in
combined businesses: 41200 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
13. Other results :
41300 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.1) OPERATING INCOME (1 + 2 +
3 + 4 + 5 + 6 + 7 + 8 + 9 + 10 + 11 + 12 + 13) : 49100 |
10.642.000,00 |
8.954.000,00 |
9.772.000,00 |
4.292.621,00 |
3.133.942,00 |
|
14. Financial income :
41400 |
213.000,00 |
71.000,00 |
47.000,00 |
60.598,00 |
3.139,00 |
|
a) Of
shares in equity instruments : 41410 |
213.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a 1) In Group companies and associates: 41411 |
136.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a 2) In third parties: 41412 |
77.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) From
negotiable securities and other financial instruments : 41420 |
0,00 |
71.000,00 |
47.000,00 |
60.598,00 |
3.139,00 |
|
b 1) From Group companies and associates : 41421 |
0,00 |
42.000,00 |
42.000,00 |
15.551,00 |
0,00 |
|
b 2) From third parties : 41422 |
0,00 |
29.000,00 |
5.000,00 |
45.047,00 |
3.139,00 |
|
c)
Allocation of financial subsidies, donations and legacies : 41430 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
15. Financial expenditure:
41500 |
-453.000,00 |
-278.000,00 |
-343.000,00 |
-372.290,00 |
-254.500,00 |
|
a) Amounts
owed to Group companies and associates : 41510 |
0,00 |
0,00 |
-148.000,00 |
-102.264,00 |
0,00 |
|
b) For
debts with third parties : 41520 |
-453.000,00 |
-278.000,00 |
-195.000,00 |
-270.026,00 |
-254.500,00 |
|
c) Stock renewal
: 41530 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
16. Changes in fair value of
financial instruments : 41600 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a)
Trading book and other : 41610 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b)
Allocation of financial assets held for sale to the result for the period:
41620 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
17. Exchange rate differences
: 41700 |
-149.000,00 |
-251.000,00 |
-7.000,00 |
96.664,00 |
-42.147,00 |
|
18. Impairment and result for
transfers of financial instruments: 41800 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a)
Impairment and losses : 41810 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b)
Results for transfers and other : 41820 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
19. Other financial income and
expenditure: 42100 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a)
Incorporation of financial expenditure to assets: 42110 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Financial
income from arrangement with creditors: 42120 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) Other
income and expenditure: 42130 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.2) FINANCIAL REVENUE
(14+15+16+17+18+19) : 49200 |
-389.000,00 |
-458.000,00 |
-303.000,00 |
-215.028,00 |
-293.508,00 |
|
A.3) NET RESULT BEFORE TAXES
(A.1+A.2) : 49300 |
10.253.000,00 |
8.496.000,00 |
9.469.000,00 |
4.077.593,00 |
2.840.433,00 |
|
20. Income taxes: 41900 |
-2.358.000,00 |
-2.031.000,00 |
-2.341.000,00 |
-1.179.663,00 |
-675.884,00 |
|
A.4) PROFIT AFTER TAXES
(A.3+20) : 49400 |
7.895.000,00 |
6.465.000,00 |
7.128.000,00 |
2.897.929,00 |
2.164.549,00 |
|
21. Result of the year coming
from interrupted operations : 42000 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.5) RESULT OF THE PERIOD
(A.4+21) : 49500 |
7.895.000,00 |
6.465.000,00 |
7.128.000,00 |
2.897.929,00 |
2.164.549,00 |
> Normal Balance Sheet under the rules of the 1990 General Accounting Plan (repealed since 1st January of 2008)
Information
corresponding to the fiscal year
2013 2012 2011 2010 2009 has been compiled based on
the equivalence criteria stipulated in Act JUS/206/2009. Where the provisions
of the Act did not establish relevant equivalence criteria, To view details on
the methodology 2013 2012 2011 2010 2009 is taken
from information submitted to the TRADE REGISTER.
|
|
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
|
ASSETS |
2013 |
2012 |
2011 |
2010 |
2009 |
|
A) SHAREHOLDERS (PARTNERS) BY
UNCALLED SUSCRIBED CAPITAL: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B) FIXED ASSETS: |
20.549.000,00 |
13.908.000,00 |
13.152.000,00 |
9.097.397,00 |
10.593.983,00 |
|
I.
Formation expenses: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Intangible fixed assets: |
1.475.000,00 |
1.907.000,00 |
3.150.000,00 |
987.256,00 |
1.537.343,00 |
|
1. Research and development costs: |
140.000,00 |
310.000,00 |
630.000,00 |
987.256,00 |
1.536.825,00 |
|
2. Concessions, patents, licences, trademarks et al.: |
526.000,00 |
896.000,00 |
1.820.000,00 |
0,00 |
0,00 |
|
3. Goodwill: |
699.000,00 |
699.000,00 |
699.000,00 |
0,00 |
0,00 |
|
4. Key money paid for premises: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Software: |
110.000,00 |
2.000,00 |
1.000,00 |
0,00 |
517,00 |
|
6. Assets under capital leases: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Payments on account: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
8. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
9. Accumulated depreciation: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Tangible fixed assets: |
7.861.000,00 |
8.372.000,00 |
9.983.000,00 |
8.098.781,00 |
8.268.989,00 |
|
1. Land and construction: |
3.790.000,00 |
3.907.000,00 |
3.986.000,00 |
3.072.614,00 |
2.805.346,00 |
|
2. Technical installations and machinery: |
3.104.537,00 |
4.026.992,00 |
5.336.605,00 |
4.314.062,00 |
4.765.212,00 |
|
3. Other installations, tools and furniture: |
68.016,00 |
88.226,00 |
116.918,00 |
94.515,00 |
104.399,00 |
|
4. Payments on account and tangible fixed assets under
construction: |
655.000,00 |
34.000,00 |
125.000,00 |
279.298,00 |
220.361,00 |
|
5. Other tangible assets: |
243.447,00 |
315.782,00 |
418.477,00 |
338.293,00 |
373.671,00 |
|
6. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Accumulated depreciation: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Financial investments: |
11.213.000,00 |
3.629.000,00 |
19.000,00 |
11.360,00 |
787.651,00 |
|
1. Equity investments in group companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Receivables from group companies: |
11.194.000,00 |
3.610.000,00 |
0,00 |
0,00 |
777.537,00 |
|
3. Equity investment in associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Credits to associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Long-term securities portfolio: |
10.000,00 |
10.000,00 |
10.000,00 |
5.730,00 |
5.730,00 |
|
6. Other receivables: |
9.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Long term guarantees and deposits: |
0,00 |
9.000,00 |
9.000,00 |
5.630,00 |
4.384,00 |
|
8. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
9. Long-term receivables from public bodies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V. Own
shares: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Long-term trade receivables: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
C) Deferred expenses: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
D) CURRENT ASSETS: |
37.604.000,00 |
36.560.000,00 |
31.576.000,00 |
23.165.159,00 |
16.629.923,00 |
|
I.
Called-up share capital (not paid): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Stocks: |
18.195.000,00 |
15.047.000,00 |
15.559.000,00 |
10.350.520,00 |
8.261.684,00 |
|
1. Goods for resale: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Raw materials and other consumables: |
4.428.000,00 |
3.471.000,00 |
3.968.000,00 |
2.972.693,00 |
1.972.894,00 |
|
3. Goods in process and semifinished ones: |
5.945.000,00 |
5.622.000,00 |
3.480.000,00 |
2.183.866,00 |
2.859.094,00 |
|
4. Finished products: |
7.801.000,00 |
5.885.000,00 |
8.110.000,00 |
5.186.500,00 |
3.429.696,00 |
|
5. Byproducts, scrap and recovered materials: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
6. Payments on account: |
21.000,00 |
69.000,00 |
1.000,00 |
7.461,00 |
0,00 |
|
7. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Debtors: |
16.386.000,00 |
15.552.000,00 |
13.573.000,00 |
10.304.321,00 |
7.042.689,00 |
|
1. Trade debtors / accounts receivable: |
12.340.000,00 |
12.439.000,00 |
10.598.000,00 |
9.212.908,00 |
4.504.213,00 |
|
2. Accounts receivable, Group companies: |
2.233.000,00 |
1.647.000,00 |
1.516.000,00 |
411.571,00 |
976.192,00 |
|
3. Accounts receivable, associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Other debtors: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Staff: |
5.000,00 |
6.000,00 |
0,00 |
0,00 |
37.648,00 |
|
6. Public bodies: |
1.808.000,00 |
1.460.000,00 |
1.459.000,00 |
679.843,00 |
1.524.636,00 |
|
7. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Short-term investments: |
0,00 |
2.800.000,00 |
0,00 |
10.000,00 |
0,00 |
|
1. Equity investments in group companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Receivables from group companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Equity investment in associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Credits to associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Short term securities portfolio: |
0,00 |
2.800.000,00 |
0,00 |
10.000,00 |
0,00 |
|
6. Other receivables: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
7. Shor term guarantees and deposits: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
8. Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V.
Short-term treasury shares: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI. Cash
at bank and in hand: |
3.023.000,00 |
3.161.000,00 |
2.444.000,00 |
2.500.318,00 |
1.325.550,00 |
|
VII.
Prepayments and accrued income: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
GENERAL TOTAL (A + B + C + D):
|
58.153.000,00 |
50.468.000,00 |
44.728.000,00 |
32.262.556,00 |
27.223.906,00 |
MERCANTILE REGISTRY.
|
|
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
|
LIABILITIES |
2013 |
2012 |
2011 |
2010 |
2009 |
|
A) EQUITY: |
30.564.100,00 |
29.655.600,00 |
25.665.800,00 |
12.551.997,00 |
12.453.672,00 |
|
I.
Subscribed capital: |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
2.000.000,00 |
|
II. Share
premium: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Revaluation reserves: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV.
Reserves: |
20.669.100,00 |
21.190.600,00 |
16.537.800,00 |
7.654.068,00 |
8.289.123,00 |
|
1. Legal reserve: |
400.000,00 |
400.000,00 |
400.000,00 |
400.000,00 |
400.000,00 |
|
2. Reserves for own shares: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Reserves for shares of the controlling company: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Statutory reserves: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
5. Miscellaneous reserves: |
20.269.100,00 |
20.790.600,00 |
16.137.800,00 |
7.254.068,00 |
7.889.123,00 |
|
Differences due to capital adjustement to euros: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V. Profit
or loss brought forward: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Retained earnings: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Prior year losses: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Partners' contributions so as to compensate losses:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Profit or loss for the financial year: |
7.895.000,00 |
6.465.000,00 |
7.128.000,00 |
2.897.929,00 |
2.164.549,00 |
|
VII.
Interim dividend paid: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VIII. Own
shares for capital reduction: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B) Deferred income: |
242.900,00 |
414.400,00 |
585.200,00 |
668.725,00 |
791.592,00 |
|
1. Capital grants: |
242.900,00 |
414.400,00 |
585.200,00 |
668.725,00 |
791.592,00 |
|
2. Unrealised exchange gains: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Other deferred income: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Public revenues to distribute in several financial years:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
C) PROVISIONS FOR LIABILITIES
AND CHARGES: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Provisions for pension fund and other similar obligations:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Provisions for taxes: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Other provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Reversion fund: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
D) LONG TERM LIABILITIES:
|
5.559.000,00 |
3.437.000,00 |
3.331.000,00 |
9.105.589,00 |
1.455.952,00 |
|
I. Issued
debentures and other marketable securities: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Non-convertible debentures: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Convertible debentures: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Other debt securities: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Amounts owed to credit institutions: |
4.831.000,00 |
2.235.000,00 |
1.324.000,00 |
2.110.430,00 |
769.153,00 |
|
1. Loans and other liabilities: |
4.831.000,00 |
2.235.000,00 |
1.324.000,00 |
2.110.430,00 |
769.153,00 |
|
2. Long-term liabilities from capital leases: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III. Debts
with companies of the group and affiliated ones: |
0,00 |
0,00 |
242.000,00 |
5.574.433,00 |
0,00 |
|
1. Amounts owed to group companies: |
0,00 |
0,00 |
242.000,00 |
5.574.433,00 |
0,00 |
|
2. Amounts owed to associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV. Other
creditors: |
728.000,00 |
1.202.000,00 |
1.765.000,00 |
1.420.726,00 |
686.798,00 |
|
1. Long-term bills of exchange payable: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Other creditors: |
108.000,00 |
376.000,00 |
644.000,00 |
951.843,00 |
122.865,00 |
|
3. Long term guarantees and deposits received: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Long term payables to public bodies: |
620.000,00 |
826.000,00 |
1.121.000,00 |
468.883,00 |
563.934,00 |
|
V. Unpaid
portion of equity investment: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Group companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Third parties: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI. Long
term trade creditors: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
E) SHORT TERM CREDITORS:
|
21.787.000,00 |
16.961.000,00 |
15.146.000,00 |
9.936.245,00 |
12.522.691,00 |
|
I. Issued
debentures and other marketable securities: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
1. Non-convertible debentures: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
2. Convertible debentures: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Other debt securities: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
4. Accrued interest on debentures and other debt securities:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
II.
Amounts owed to credit institutions: |
7.737.000,00 |
5.985.000,00 |
3.191.000,00 |
1.584.028,00 |
2.908.525,00 |
|
1. Loans and other liabilities: |
7.737.000,00 |
5.985.000,00 |
3.191.000,00 |
1.584.028,00 |
2.908.525,00 |
|
2. Accrued interest on liabilities with credit institutions:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Short-term liabilities from capital leases: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
III.
Short-term amounts owed to group and associated companies: |
3.368.000,00 |
2.525.000,00 |
3.034.000,00 |
1.558.629,00 |
6.508.611,00 |
|
1. Amounts owed to group companies: |
3.368.000,00 |
2.525.000,00 |
3.034.000,00 |
1.558.629,00 |
6.508.611,00 |
|
2. Amounts owed to associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
IV. Trade
creditors: |
9.328.000,00 |
7.315.000,00 |
7.899.000,00 |
5.954.552,00 |
2.623.806,00 |
|
1. Advanced payments from customers: |
581.000,00 |
152.000,00 |
0,00 |
99.122,00 |
50.525,00 |
|
2. Amounts owed for purchases of goods or services: |
8.747.000,00 |
7.163.000,00 |
7.899.000,00 |
5.855.430,00 |
2.573.281,00 |
|
3. Debts represented by notes payable: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
V. Other creditors:
|
1.354.000,00 |
1.136.000,00 |
1.022.000,00 |
839.035,00 |
481.750,00 |
|
1. Public bodies: |
364.000,00 |
309.000,00 |
262.000,00 |
204.629,00 |
166.433,00 |
|
2. Bills of exchange payable: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
3. Miscellaneous debts: |
434.000,00 |
310.000,00 |
324.000,00 |
324.054,00 |
39.214,00 |
|
4. Wages and salaries payable: |
556.000,00 |
517.000,00 |
436.000,00 |
310.352,00 |
276.103,00 |
|
5. Guarantees and deposits received at short term: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VI.
Provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
VII.
Prepayments and accrued income: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
F) SHORT-TERM PROVISIONS FOR
LIABILITIES AND CHARGES: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
GENERAL TOTAL (A + B + C + D +
E + F): |
58.153.000,00 |
50.468.000,00 |
44.728.000,00 |
32.262.556,00 |
27.223.906,00 |
MERCANTILE REGISTRY.
|
|
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
|
DEBIT |
2013 |
2012 |
2011 |
2010 |
2009 |
|
A) CHARGES (A.1 to A.15):
|
54.543.000,00 |
52.615.000,00 |
45.995.000,00 |
32.469.839,00 |
23.431.547,00 |
|
A.1. Stock reduction of both manufactured goods and the ones in
process: |
0,00 |
84.000,00 |
0,00 |
0,00 |
0,00 |
|
A.2. Supplies: |
36.227.000,00 |
34.761.000,00 |
26.847.000,00 |
20.842.429,00 |
14.029.246,00 |
|
a) Stock consumption: |
0,00 |
2.571.000,00 |
2.757.000,00 |
2.221.387,00 |
1.494.504,00 |
|
b) Consumption of raw materials and
miscellaneous consumable ones: |
33.821.000,00 |
28.834.000,00 |
20.251.000,00 |
17.193.455,00 |
11.635.881,00 |
|
c) Miscellaneous external expenditure:
|
2.406.000,00 |
3.356.000,00 |
3.839.000,00 |
1.427.587,00 |
898.861,00 |
|
A.3. Staff costs: |
6.914.000,00 |
6.476.000,00 |
4.918.000,00 |
3.509.813,00 |
3.427.413,00 |
|
a) Wages, salaries et al.: |
5.221.000,00 |
4.901.000,00 |
3.691.000,00 |
2.634.583,00 |
2.531.002,00 |
|
b) Social security costs: |
1.693.000,00 |
1.575.000,00 |
1.227.000,00 |
875.230,00 |
896.411,00 |
|
A.4. Depreciation expense: |
2.094.000,00 |
3.108.000,00 |
4.455.000,00 |
2.112.272,00 |
1.929.221,00 |
|
A.5. Variation of trade provisions and losses of unrecovered
receivables: |
0,00 |
0,00 |
20.000,00 |
3.592,00 |
1.110,00 |
|
a) Stock provision variation: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) Variation in provision and bad debt
losses: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) Variation of other trade provisions:
|
0,00 |
0,00 |
20.000,00 |
3.592,00 |
1.110,00 |
|
A.6. Other operating charges: |
6.348.000,00 |
5.626.000,00 |
7.060.000,00 |
4.448.885,00 |
3.046.336,00 |
|
a) External services: |
6.073.000,00 |
5.410.000,00 |
7.028.000,00 |
4.176.193,00 |
3.025.546,00 |
|
b) Taxes: |
23.000,00 |
43.000,00 |
32.000,00 |
16.199,00 |
17.270,00 |
|
c) Other operating expenses: |
252.000,00 |
173.000,00 |
0,00 |
256.493,00 |
3.520,00 |
|
d) Allocation to revision fund: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.I.
OPERATING BENEFITS (B.1+B.2+B.3+B.4-A.1-A.2-A.3-A.4-A.5-A.6): |
10.293.000,00 |
8.606.000,00 |
9.423.000,00 |
3.890.369,00 |
2.815.044,00 |
|
A.7. Financial and similar charges: |
453.000,00 |
278.000,00 |
343.000,00 |
372.290,00 |
254.500,00 |
|
a) Due to liabilities with companies of
the group: |
0,00 |
0,00 |
148.000,00 |
102.264,00 |
0,00 |
|
b) Due to liabilities with associated
companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) Due to other debts.: |
453.000,00 |
278.000,00 |
195.000,00 |
270.026,00 |
254.500,00 |
|
d) Losses from financial investments:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.8. Changes in financial investment provisions: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.9. Exchange losses: |
149.000,00 |
251.000,00 |
7.000,00 |
0,00 |
42.147,00 |
|
A.II. NET
FINANCIAL INCOME (B.5+B.6+B.7+B.8-A.7-A.8-A.9): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.III.
PROFIT FROM ORDINARY ACTIVITIES (A.I+A.II-B.I-B.II): |
9.904.000,00 |
8.148.000,00 |
9.120.000,00 |
3.675.341,00 |
2.521.535,00 |
|
A.10. Changes in provisions for intangible, tangible and
securities portfolio: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.11. Losses from tangible and intangible fixed assets and
securities portfolio: |
0,00 |
0,00 |
4.000,00 |
895,00 |
25.689,00 |
|
A.12. Losses from transactions with own shares and debentures:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.13. Extraordinary expenses: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.14. Expenses and losses of former financial years: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.IV.
EXTRAORDINARY PROFIT (B.9+B.10+B.11+B.12+B.13-A.10-A.11-A.12-A.13-A.14):
|
349.000,00 |
348.000,00 |
349.000,00 |
402.252,00 |
318.898,00 |
|
A.V.
PROFIT BEFORE TAXES (A.III+A.IV-B.III-B.IV): |
10.253.000,00 |
8.496.000,00 |
9.469.000,00 |
4.077.593,00 |
2.840.433,00 |
|
A.15. Corporation tax: |
2.358.000,00 |
2.031.000,00 |
2.341.000,00 |
1.179.663,00 |
675.884,00 |
|
A.16. Miscellaneous taxes: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
A.VI.
FINANCIAL YEAR RESULTS (PROFIT) (A.V-A.15-A.16): |
7.895.000,00 |
6.465.000,00 |
7.128.000,00 |
2.897.929,00 |
2.164.549,00 |
MERCANTILE REGISTRY.
|
|
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
EQUIVALENCIA |
|
CREDIT |
2013 |
2012 |
2011 |
2010 |
2009 |
|
B) INCOME ( B.1 to B.13):
|
62.438.000,00 |
59.080.000,00 |
53.123.000,00 |
35.367.769,00 |
25.596.096,00 |
|
B.1. Net total sales: |
59.275.000,00 |
58.580.000,00 |
49.097.000,00 |
33.367.837,00 |
22.716.871,00 |
|
a) Sales: |
59.040.000,00 |
58.453.000,00 |
49.029.000,00 |
32.900.587,00 |
22.492.865,00 |
|
b) Rendering of services: |
235.000,00 |
127.000,00 |
68.000,00 |
467.250,00 |
224.006,00 |
|
Returns and Rappel on sales: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.2. Stock increase of manufactured goods and products in
process: |
2.240.000,00 |
0,00 |
2.872.000,00 |
1.081.575,00 |
1.284.548,00 |
|
B.3. Works performed by the company for fixed assets: |
0,00 |
0,00 |
0,00 |
0,00 |
573.491,00 |
|
B.4. Miscellaneous operating income: |
361.000,00 |
81.000,00 |
754.000,00 |
357.948,00 |
673.460,00 |
|
a) Auxiliary income and other from current
management: |
355.000,00 |
79.000,00 |
152.000,00 |
146.275,00 |
468.404,00 |
|
b) Grants: |
6.000,00 |
2.000,00 |
602.000,00 |
211.673,00 |
205.057,00 |
|
c) Liabilities and charges provisions
surplus: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.I.
PÉRDIDAS DE EXPLOTACIÓN (A.1+A.2+A.3+A.4+A.5-A.6-B.1-B.2-B.3-B.4): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.5. Income from equity investment: |
213.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a) In companies of the group: |
136.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) In associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) Third parties: |
77.000,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.6. Income from other marketable securities and long-term
receivables: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
a) From companies of the group: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
b) From associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) From companies out of the group: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.7. Miscellaneous interests or similar income: |
0,00 |
71.000,00 |
47.000,00 |
60.598,00 |
3.139,00 |
|
a) From companies of the group: |
0,00 |
42.000,00 |
42.000,00 |
15.551,00 |
0,00 |
|
b) From associated companies: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
c) Miscellaneous interests: |
0,00 |
29.000,00 |
5.000,00 |
45.047,00 |
3.139,00 |
|
d) Profit on financial investment: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.8. Exchange positive differences: |
0,00 |
0,00 |
0,00 |
96.664,00 |
0,00 |
|
B.II.
NEGATIVE FINANCIAL RESULTS (A.7+A.8+A.9-B.5-B.6-B.7-B.8): |
389.000,00 |
458.000,00 |
303.000,00 |
215.028,00 |
293.508,00 |
|
B.III. LOSSES
ON ORDINARY ACTIVITIES ( B.I + B.II - A.I - A.II ): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.9.Profit on disposal of both tangible and intangible fixed
assets and securities portfolio: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.10. Profit on transactions with own shares and debentures:
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.11. Capital grants transferred to profit and loss: |
349.000,00 |
348.000,00 |
353.000,00 |
403.147,00 |
344.587,00 |
|
B.12. Extraordinary income: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.13. Income and profit of former financial years: |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.IV.
NEGATIVE EXTRAORDINARY RESULTS (A.10+A.11+A.12+A.13+A.14-B.9-B.10-B.11-B.12-B.13):
|
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.V.
LOSSES BEFORE TAXES (B.III+B.IV-A.III-A.IV): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
|
B.VI. RESULT
OF THE PERIOD (LOSSES) (B.V+A.15+A.16): |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
MERCANTILE REGISTRY.
CASHFLOW
STATEMENT
Model: Normal
> Source of information: Data contained in this section is taken from the information declared in the Annual Accounts submitted to the Trade Register.
|
|
2013 |
2012 |
2011 |
2010 |
2009 |
|
1. Fiscal year result before
taxes.: 61100 |
10.253.000,00 |
8.496.000,00 |
9.469.000,00 |
4.077.593,00 |
2.840.433,00 |
|
2. Results adjustments.:
61200 |
2.134.000,00 |
3.218.000,00 |
4.405.000,00 |
1.925.048,00 |
1.899.832,00 |
|
a) Fixed
Assets Amortization (+).: 61201 |
2.094.000,00 |
3.108.000,00 |
4.455.000,00 |
2.112.272,00 |
1.929.221,00 |
|
d)
Allocation of grants (-).: 61204 |
-349.000,00 |
-348.000,00 |
-353.000,00 |
-403.147,00 |
-344.587,00 |
|
e)
Results on disposal of fixed assets (+/-). : 61205 |
0,00 |
0,00 |
0,00 |
895,00 |
25.689,00 |
|
g)
Financial income (-).: 61207 |
-213.000,00 |
-71.000,00 |
-47.000,00 |
-60.598,00 |
-3.139,00 |
|
h)
Financial Expenses (+). : 61208 |
453.000,00 |
278.000,00 |
343.000,00 |
372.290,00 |
254.500,00 |
|
i) Exchange
differences (+/-). : 61209 |
149.000,00 |
251.000,00 |
7.000,00 |
-96.664,00 |
42.147,00 |
|
k) Other
income and expense (-/+). : 61211 |
0,00 |
0,00 |
0,00 |
0,00 |
-4.000,00 |
|
3. Changes in current capital
equity.: 61300 |
-1.671.000,00 |
-2.349.000,00 |
-2.454.000,00 |
-3.744.668,00 |
-75.000,00 |
|
a) Stock
(+/-).: 61301 |
-3.148.000,00 |
512.000,00 |
-3.084.000,00 |
-2.088.836,00 |
-408.513,00 |
|
d) Debtors
and other accounts receivable (+/-). : 61302 |
-1.195.000,00 |
-1.972.000,00 |
287.000,00 |
-3.508.404,00 |
-1.142.000,00 |
|
d)
Creditors and other accounts payable (+/-). : 61304 |
2.672.000,00 |
-889.000,00 |
343.000,00 |
1.852.572,00 |
1.475.513,00 |
|
4. Other cash flows for
operating activities.: 61400 |
-2.432.000,00 |
-2.717.000,00 |
-2.980.000,00 |
-829.128,00 |
-294.361,00 |
|
a)
Interest payments (-). : 61401 |
-422.000,00 |
-271.000,00 |
-343.000,00 |
-372.290,00 |
-254.500,00 |
|
b)
Dividend payment collection (+). : 61402 |
213.000,00 |
71.000,00 |
0,00 |
0,00 |
3.139,00 |
|
c)
Interest collection (+). : 61403 |
0,00 |
0,00 |
47.000,00 |
60.598,00 |
0,00 |
|
d) Income
tax payment collection (payments) (+/-).: 61404 |
-2.223.000,00 |
-2.517.000,00 |
-2.684.000,00 |
-517.437,00 |
-43.000,00 |
|
5. Operating activity cash
flows (1 + 2 + 3 + 4) : 61500 |
8.284.000,00 |
6.648.000,00 |
8.440.000,00 |
1.428.845,00 |
4.370.904,00 |
|
6. Payments for investment
(-).: 62100 |
-8.611.000,00 |
-3.864.000,00 |
-776.000,00 |
-1.394.118,00 |
-890.000,00 |
|
a)
Companies of the group and affiliates. : 62101 |
-7.584.000,00 |
-3.610.000,00 |
0,00 |
0,00 |
0,00 |
|
b)
Intangible fixed assets. : 62102 |
-74.000,00 |
-2.000,00 |
-1.000,00 |
0,00 |
-573.000,00 |
|
c) Fixed
assets. : 62103 |
-953.000,00 |
-252.000,00 |
-775.000,00 |
-1.392.872,00 |
-316.000,00 |
|
e) Other
financial assets. : 62105 |
0,00 |
0,00 |
0,00 |
-1.246,00 |
0,00 |
|
h) Other
assets. : 62108 |
0,00 |
0,00 |
0,00 |
0,00 |
-1.000,00 |
|
7. Divestment payment
collection (+). : 62200 |
0,00 |
0,00 |
0,00 |
777.537,00 |
33.000,00 |
|
a)
Companies of the group and affiliates. : 62201 |
0,00 |
0,00 |
0,00 |
777.537,00 |
0,00 |
|
c) Fixed
assets. : 62203 |
0,00 |
0,00 |
0,00 |
0,00 |
9.000,00 |
|
e) Other
financial assets. : 62205 |
0,00 |
0,00 |
0,00 |
0,00 |
24.000,00 |
|
8. Investment activity cash
flows (6 + 7) minus Amortization: 62300 |
-8.611.000,00 |
-3.864.000,00 |
-776.000,00 |
-616.581,00 |
-857.000,00 |
|
9. Payment collection and payments
for equity instruments. : 63100 |
360.000,00 |
0,00 |
0,00 |
152.399,00 |
1.055.000,00 |
|
e)
Grants, donations and bequests received (+). : 63105 |
360.000,00 |
0,00 |
0,00 |
152.399,00 |
1.055.000,00 |
|
10. Payment collection and
payments for financial liabilities instruments.: 63200 |
4.049.000,00 |
3.133.000,00 |
-6.695.000,00 |
2.894.290,00 |
-3.770.000,00 |
|
a)
Issuance : 63201 |
4.334.000,00 |
4.487.000,00 |
2.403.000,00 |
5.996.583,00 |
1.905.000,00 |
|
2. Debts
incurred with credit institutions (+). : 63203 |
4.334.000,00 |
4.487.000,00 |
0,00 |
2.500.000,00 |
0,00 |
|
3. Debts
incurred with companies of the group and affiliates (+).: 63204 |
0,00 |
0,00 |
0,00 |
1.818.183,00 |
1.905.000,00 |
|
5. Other
debts (+). : 63206 |
0,00 |
0,00 |
2.403.000,00 |
1.678.400,00 |
0,00 |
|
b)
Repayment and amortization of : 63207 |
-285.000,00 |
-1.354.000,00 |
-9.098.000,00 |
-3.102.292,00 |
-5.675.000,00 |
|
2. Debts
incurred with credit institutions (-).: 63209 |
0,00 |
-788.000,00 |
-1.763.000,00 |
-2.493.398,00 |
-5.636.000,00 |
|
3. Debts
incurred with companies of the group and affiliates (-). : 63210 |
0,00 |
-242.000,00 |
-6.078.000,00 |
0,00 |
0,00 |
|
5. Other
debts (-). : 63212 |
-285.000,00 |
-324.000,00 |
-1.257.000,00 |
-608.894,00 |
-39.000,00 |
|
11. Payments from dividends
and remunerations from other assets instruments. : 63300 |
-6.900.000,00 |
-2.400.000,00 |
-1.500.000,00 |
-2.750.000,00 |
-280.000,00 |
|
a)
Dividends (-).: 63301 |
-6.900.000,00 |
-2.400.000,00 |
-1.500.000,00 |
-2.750.000,00 |
-280.000,00 |
|
12. Cash flows for financing activities
(9+10+11).: 63400 |
-2.491.000,00 |
733.000,00 |
-8.195.000,00 |
296.689,00 |
-2.995.000,00 |
|
D) EFFECT OF EXCHANGE RATE
CHANGES: 64000 |
-120.000,00 |
0,00 |
-42.000,00 |
75.815,00 |
-94.084,00 |
|
E) NET INCREASE/DECREASE OF CASH
OR EQUIVALENT ASSETS (+/-5+/-8+/12+/-D) : 65000 |
-2.938.000,00 |
3.517.000,00 |
-573.000,00 |
1.184.768,00 |
424.820,00 |
|
Cash or
equivalent assets as of beginning of the fiscal year.: 65100 |
5.961.000,00 |
2.444.000,00 |
3.017.000,00 |
1.325.550,00 |
900.730,00 |
|
Cash or
equivalent assets as of end of the fiscal year.: 65200 |
3.023.000,00 |
5.961.000,00 |
2.444.000,00 |
2.510.318,00 |
1.325.550,00 |
FINANCIAL
DIAGNOSIS
> Economic-Financial
Comparative Analysis
Data used in the
following ratios and indicators is taken from the Annual Accounts submitted by
the company to the TRADE REGISTER.
> Comparison within the
Sector
|
Cash Flow |
2013 |
2012 |
Variación
2013 - 2012 |
|||
|
|
Empresa |
Sector |
Empresa |
Sector |
Empresa |
Sector |
|
Cash Flow over Sales: |
-0,05
% |
0,01
% |
0,06
% |
0,01
% |
-182,56
% |
116,03
% |
|
EBITDA over Sales: |
20,90
% |
11,40
% |
20,00
% |
9,18
% |
4,51
% |
24,12
% |
|
Cash Flow Yield: |
-0,05
% |
0,01
% |
0,07
% |
0,00
% |
-172,50
% |
|
|
Profitability |
2013 |
2012 |
Variación
2013 - 2012 |
|||
|
|
Empresa |
Sector |
Empresa |
Sector |
Empresa |
Sector |
|
Operating economic
profitability: |
22,67
% |
6,99
% |
19,12
% |
5,14
% |
18,60
% |
36,03
% |
|
Total economic profitability:
|
18,41
% |
3,84
% |
17,39
% |
2,46
% |
5,89
% |
55,86
% |
|
Financial profitability:
|
25,93
% |
4,46
% |
21,95
% |
1,25
% |
18,13
% |
255,74
% |
|
Margin: |
17,84
% |
6,76
% |
15,26
% |
4,79
% |
16,91
% |
41,21
% |
|
Mark-up: |
17,19
% |
4,63
% |
14,48
% |
1,53
% |
18,71
% |
201,92
% |
|
Solvency |
2013 |
2012 |
Variación
2013 - 2012 |
|||
|
|
Empresa |
Sector |
Empresa |
Sector |
Empresa |
Sector |
|
Liquidity: |
0,14 |
0,13 |
0,35 |
0,12 |
-60,41 |
14,16 |
|
Acid Test: |
0,88 |
0,86 |
1,26 |
0,85 |
-30,41 |
0,70 |
|
Working Capital / Investment:
|
0,27 |
0,05 |
0,39 |
0,03 |
-30,90 |
88,26 |
|
Solvency: |
1,72 |
1,18 |
2,15 |
1,17 |
-19,70 |
0,07 |
|
Indebtedness |
2013 |
2012 |
Variación
2013 - 2012 |
|||
|
|
Empresa |
Sector |
Empresa |
Sector |
Empresa |
Sector |
|
Indebtedness level: |
0,89 |
1,36 |
0,68 |
1,63 |
30,49 |
-16,64 |
|
Borrowing Composition: |
0,25 |
0,99 |
0,20 |
1,03 |
26,27 |
-3,97 |
|
Repayment Ability: |
-9,32 |
87,26 |
5,82 |
201,56 |
-260,10 |
-56,71 |
|
Warranty: |
2,12 |
1,75 |
2,47 |
1,62 |
-13,84 |
7,71 |
|
Generated resources / Total creditors:
|
0,36 |
0,08 |
0,47 |
0,07 |
-21,98 |
27,43 |
|
Efficiency |
2013 |
2012 |
Variación
2013 - 2012 |
|||
|
|
Empresa |
Sector |
Empresa |
Sector |
Empresa |
Sector |
|
Productivity: |
2,79 |
1,87 |
2,81 |
1,72 |
-0,61 |
8,64 |
|
Turnover of Collection Rights
: |
3,71 |
5,08 |
3,80 |
4,78 |
-2,22 |
6,12 |
|
Turnover of Payment
Entitlements: |
4,10 |
3,67 |
4,77 |
3,52 |
-14,04 |
4,32 |
|
Stock rotation: |
2,71 |
7,33 |
3,33 |
6,47 |
-18,48 |
13,30 |
|
Assets turnover: |
1,27 |
1,03 |
1,25 |
1,07 |
1,44 |
-3,67 |
|
Borrowing Cost: |
1,66 |
2,83 |
1,36 |
2,95 |
21,84 |
-4,01 |
> Trend of
indicators under the General Accounting Plan of 2007 (2013, 2012, 2011, 2010,
2009)
|
Cash Flow |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Cash Flow over Sales: |
-0,05
% |
0,06
% |
0,00
% |
3,55
% |
1,87
% |
|
EBITDA over Sales: |
20,90
% |
20,00
% |
28,27
% |
17,99
% |
20,88
% |
|
Cash Flow Yield: |
-0,05
% |
0,07
% |
0,00
% |
3,67
% |
1,56
% |
|
Profitability |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Operating economic
profitability: |
22,67
% |
19,12
% |
21,86
% |
13,31
% |
11,85
% |
|
Total economic profitability:
|
18,41
% |
17,39
% |
21,94
% |
13,79
% |
11,37
% |
|
Financial profitability:
|
25,93
% |
21,95
% |
28,07
% |
23,66
% |
17,89
% |
|
Margin: |
17,84
% |
15,26
% |
19,60
% |
12,73
% |
13,08
% |
|
Mark-up: |
17,19
% |
14,48
% |
18,99
% |
12,09
% |
11,85
% |
|
Solvency |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Liquidity: |
0,14 |
0,35 |
0,16 |
0,25 |
0,11 |
|
Acid Test: |
0,88 |
1,26 |
1,04 |
1,27 |
0,63 |
|
Working Capital / Investment:
|
0,27 |
0,39 |
0,36 |
0,40 |
0,13 |
|
Solvency: |
1,72 |
2,15 |
2,08 |
2,32 |
1,32 |
|
Indebtedness |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Indebtedness level: |
0,89 |
0,68 |
0,71 |
1,45 |
1,06 |
|
Borrowing Composition: |
0,25 |
0,20 |
0,22 |
0,91 |
0,12 |
|
Repayment Ability: |
-9,32 |
5,82 |
-279,68 |
3,18 |
2,96 |
|
Warranty: |
2,12 |
2,47 |
2,41 |
1,69 |
1,94 |
|
Generated resources / Total
creditors: |
0,36 |
0,47 |
0,62 |
0,26 |
0,29 |
|
Efficiency |
2013 |
2012 |
2011 |
2010 |
2009 |
|
Productivity: |
2,79 |
2,81 |
3,82 |
2,71 |
2,38 |
|
Turnover of Collection Rights
: |
3,71 |
3,80 |
3,72 |
3,33 |
3,62 |
|
Turnover of Payment
Entitlements: |
4,10 |
4,77 |
4,04 |
3,66 |
3,67 |
|
Stock rotation: |
2,71 |
3,33 |
2,60 |
2,88 |
2,56 |
|
Assets turnover: |
1,27 |
1,25 |
1,12 |
1,05 |
0,91 |
|
Borrowing Cost: |
1,66 |
1,36 |
1,85 |
1,95 |
1,81 |
COMPARATIVE
SECTORIAL BALANCE
Sector-based Comparison under the rules of the New General
Accounting Plan.
|
|
Variación
- |
|
|
|
Empresa |
Sector |
|
|
Variación
- |
|
|
|
Empresa |
Sector |
|
|
Variación
- |
|
|
|
Empresa |
Sector |
Public
Tenders and Works Won
No Public Tenders assigned to the name of the company.
Detail
of Subsidies appearing in Balances Memories
|
Amount
Granted |
868.000,00 |
|
Entity |
JUNTA
DE CASTILLA Y LEON |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
503.000,00 |
|
Entity |
MINISTERIO
DE CONOMIA Y HACIENDA |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
155.000,00 |
|
Entity |
CENTRO
PARA EL DESARROLLO TECNOLOGICO INDUSTRIAL |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
152.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
137.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
123.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
122.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
117.000,00 |
|
Entity |
AGENCIA
DE DESARROLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
62.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
53.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
35.000,00 |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvencion
de explotacion. |
|
Status |
CONCEDIDA |
|
Amount
Granted |
2.000,00 |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvencion
de explotacion. |
|
Status |
CONCEDIDA |
|
Amount
Granted |
404.000,00 |
|
Notes |
Siendo
la mas importante las recibidas de la ADE por un total de 393 miles de euros. |
|
Entity |
MINISTERIO
DE ECONOMIA Y HACIENDA |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
305.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
305.000,00 |
|
Entity |
MINISTERIO
DE CONOMIA Y HACIENDA |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
49.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
JUNTA
DE CASTILLA Y LEON- |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
41.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
CENTRO
PARA EL DESARROLLO TECNOLOGICO INDUSTRIAL |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
32.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
20.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
18.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
16.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
10.000,00 |
|
Entity |
AGENCIA
DE DESARROLLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
4.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
AGENCIA
DE DESARROLO ECONOMICO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
2.000,00 |
|
Notes |
saldo
al cierre del ejrcicio. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
subvención
de capital |
|
Status |
CONCEDIDA |
|
Amount
Granted |
403.000,00 |
|
Notes |
El
importe corresponde a imputado a resultado. |
|
Entity |
JUNTA
DE CASTILLA Y LEON |
|
Subsidy
Concept |
Subvención
de Capital. Inversiones. |
|
Amount
Granted |
502.602,00 |
|
Notes |
Subvención
concedida en el año 1997. Importe pendiente a imputar a resultados es de
113.122 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de explotación. |
|
Amount
Granted |
162.298,00 |
|
Notes |
Importe
traspasado a resultados del ejercicio. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
152.657,00 |
|
Notes |
Subvención
concedida en el año 2005. Importe pendiente a imputar a resultados es de
152.657 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de Capital. Ampliación de empresa. |
|
Amount
Granted |
123.159,00 |
|
Notes |
Subvención
concedida en el año 2001. Importe pendiente a imputar a resultados es de
23.304 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
117.026,00 |
|
Notes |
Subvención
concedida en el año 2004. Importe pendiente a imputar a resultados es de
99.536 euros. |
|
Entity |
MINISTERIO
DE EDUCACION Y CIENCIAS |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
72.735,00 |
|
Notes |
Subvención
concedida en el año 2004. Importe pendiente a imputar a resultados es de
61.930 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de Capital. |
|
Amount
Granted |
68.828,00 |
|
Notes |
Subvención
concedida en el año 2001. Importe pendiente a imputar a resultados es de
23.128 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
62.537,00 |
|
Notes |
Subvención
concedida en el año 2002. Importe pendiente a imputar a resultados es de
31.269 euros. |
|
Entity |
ORGANISMO
NO ESPECIFICADO |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
53.824,00 |
|
Notes |
Subvención
concedida en varios años. Importe pendiente a imputar a resultados es de
10.157 euros. |
|
Entity |
MINISTERIO
DE CIENCIA Y TECNOLOGIA |
|
Subsidy
Concept |
Subvención
de capital. |
|
Amount
Granted |
11.340,00 |
|
Notes |
Subvención
concedida en el año 2001. Importe pendiente a imputar a resultados es de
4.393 euros. |
Research
Summary
The company was incorporated in 1996, engaged in the manufacture of pharmaceuticals. Its commercial scope is national and international. It belongs to the group of companies headed by "GADEA GRUPO FARMACÉUTICO". The consulted sources do not have any bad comment about it. According to all this information, commercial relations can be envisaged in normal credit operations.
Sources
Registry of Commerce's Official
Gazette. Own and external data bases Company References
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.63.20 |
|
|
1 |
Rs.97.10 |
|
Euro |
1 |
Rs.69.34 |
INFORMATION DETAILS
|
Analysis Done by
: |
SUB |
|
|
|
|
Report Prepared
by : |
VNT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major sections
of this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.